A member of M&R’s Intellectual Property Practice, Kathrine Brandt handles a broad array of patent, trademark and copyright matters. Ms. Brandt regularly counsels clients on the validity and infringement of intellectual property rights, and has specific expertise within the pharmaceutical, biochemical and computer technology industries.

Ms. Brandt advises pharmaceutical companies on issues ranging from disputes under the False Claims Act and False Marking Statute to patent and trademark portfolio management. She has extensive experience defending Abbreviated New Drug Applications (ANDAs) for generic, bioequivalent drugs. Ms. Brandt utilizes her strong science background and technical knowledge to provide clients with an integrated approach to ANDA and pharmaceutical patent litigation.

Ms. Brand also has broad experience in the following: Trademark, Copyright and Antitrust Litigation and Counseling; Walker-Process Fraud; Sham Litigation; Malicious Prosecution; Noerr-Pennington Immunity; False Claims Act; False Marking; Waiver and Estoppel; Standard Setting Organization Participation; Counterfeiting; Cybersquatting and DMCA claims.